Both Maternal, Paternal Substance Use Disorder Tied to Offspring Intellectual Disability
Medically reviewed by Drugs.com.
By Lori Solomon HealthDay Reporter
MONDAY, Sept. 18, 2023 -- Both paternal and maternal substance use disorder (SUD) are associated with an increased risk for intellectual disability in offspring, according to a study published in the September issue of eClinicalMedicine.
Lotfi Khemiri, from the Karolinska Institutet in Stockholm, and colleagues examined the relationship between maternal and paternal SUD (including alcohol use disorder [AUD] and drug use disorder) and the risk for intellectual disability in offspring. The analysis included 1.9 million children born in Sweden from 1978 through 2002.
The researchers found that parental SUD prior to birth was associated with an increased risk for any form of intellectual disability (odds ratio [OR], 2.3), with similar risk seen for maternal (OR, 2.3) and paternal (OR, 2.3) SUD. When adjusting for parental education, migration, psychiatric comorbidity, and coparent SUD, risk was reduced but remained significant (OR parental SUD, 1.6; OR maternal SUD, 1.4; OR paternal SUD, 1.6). The association between parental SUD and intellectual disability risk in offspring persisted irrespective of timing of diagnosis. However, if mothers or fathers were diagnosed with AUD during pregnancy (OR maternal AUD, 5.0; OR paternal AUD, 2.8), the risk was significantly greater than if the AUD diagnosis was first registered after childbirth (OR maternal AUD, 1.9; OR paternal AUD, 1.6).
"Preventative measures, such as educating health care professionals and public health recommendations, have focused for decades on mothers with alcohol-related problems," Khemiri said in a statement. "Our findings highlight the importance of also directing such measures towards fathers with different types of substance use disorder."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted September 2023
Read this next
AI-Assisted Contours Superior to Cognitively Defined Prostate Cancer Contours
WEDNESDAY, July 3, 2024 -- Artificial intelligence (AI)-assisted definition of prostate cancer contours reduces underestimation of the extent of prostate cancer, according to a...
Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million
TUESDAY, July 2, 2024 -- The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are...
Patient–Primary Care Provider Language Concordance Tied to Better Outcomes
TUESDAY, July 2, 2024 -- Patient-family physician language concordance is associated with a lower risk for adverse outcomes, according to a study published online June 3...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.